Everest Organics — 360° view

Everest Organics, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹0.80 crore for the September 2026 quarter.

Everest Organics (BSE: EVERESTO) closed at ₹219.40 on 20 Nov 2026, down 52.1% over the past year. Its market capitalisation is ₹219 crore and it trades at 44.6 times earnings.

Share price
₹219.40 (20 Nov 2026)
Market cap
₹219 Cr (20 Nov 2026)
P/E
44.65 (20 Nov 2026)
Revenue
₹48 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
12.0% (FY26)
ROE
7.63% (FY26)
Book value
₹80.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹536.40 / ₹197.00 (20 Nov 2026)
1-year return
-52.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: EVERESTO

Everest Organics Ltd (EOL) makes active pharmaceutical ingredients (APIs), the main medicinal ingredients in finished medicines, and chemical intermediates used to make APIs. Its factory is at Aroor, Sangareddy, Telangana.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.